Eli Lilly’s Orforglipron Pill Shows Promising Results for Diabetes and Weight Loss
Eli Lilly has announced promising results from its experimental pill, orforglipron, which could serve as an alternative to blockbuster injectable medications like Ozempic and Mounjaro. The oral medication is a glucagon-like peptide-1 (GLP-1) receptor agonist that can increase insulin sensitivity, delay stomach emptying, and curb hunger. The company conducted a Phase 3 trial over 40 … Read more